I alle seks undersøgelser var der en statistisk signifikant forbedring fra baseline i scoren for livskvalitet for Xolair- patienter versus placebo - eller kontrolgruppen.
For all six studies there was a statistically significant improvement from baseline in quality of life scores for Xolair patients versus the placebo or control group.